Results 121 to 130 of about 539,046 (150)

SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study. [PDF]

open access: yesProc Natl Acad Sci U S A
Chia PHJ   +13 more
europepmc   +1 more source

The central neurometabolic fingerprint of persistent spinal pain syndrome type 2: A prospective [<sup>18</sup>F]FDG PET/CT neuroimaging study. [PDF]

open access: yesNeurobiol Pain
Burmeister LS   +11 more
europepmc   +1 more source

Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy. [PDF]

open access: yesCNS Drugs
Löscher W   +4 more
europepmc   +1 more source

Lower synaptic density in mood circuitry underlies depression in Parkinson's disease. [PDF]

open access: yesBrain Commun
Cayir S   +19 more
europepmc   +1 more source

High-resolution in utero SV2A PET imaging of the nonhuman primate brain using the NeuroEXPLORER. [PDF]

open access: yesJ Cereb Blood Flow Metab
Mehta S   +15 more
europepmc   +1 more source

Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [<sup>11</sup>C]UCB-J positron emission tomography study. [PDF]

open access: yesNeuropsychopharmacology
Onwordi EC   +16 more
europepmc   +1 more source

Role of α-Synuclein in the Prefrontal Cortex: From Physiological Synaptic Modulation to Synaptic Failure in Parkinson's Disease. [PDF]

open access: yesBiomedicines
Argibay U   +7 more
europepmc   +1 more source

Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models. [PDF]

open access: yesSci Transl Med
Rao NR   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy